erlotinib zentiva 150 mg tabletki powlekane
zentiva, k.s. - erlotinibum - tabletki powlekane - 150 mg
erlotinib krka 100 mg tabletki powlekane
krka, d.d., novo mesto - erlotinibi hydrochloridum - tabletki powlekane - 100 mg
erlotinib krka 150 mg tabletki powlekane
krka, d.d., novo mesto - erlotinibi hydrochloridum - tabletki powlekane - 150 mg
erlotinib mylan 100 mg tabletki powlekane
mylan s.a.s. - erlotinibum - tabletki powlekane - 100 mg
erlotinib mylan 150 mg tabletki powlekane
mylan s.a.s. - erlotinibum - tabletki powlekane - 150 mg
erlotinib krka 25 mg tabletki powlekane
krka, d.d., novo mesto - erlotinibi hydrochloridum - tabletki powlekane - 25 mg
lorviqua
pfizer europe ma eeig - lorlatinib - rak, niedrobnokomórkowe płuca - antineoplastic agents, protein kinase inhibitors - lorviqua as monotherapy is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. lorviqua as monotherapy is indicated for the treatment of adult patients with alk‑positive advanced nsclc whose disease has progressed after:alectinib or ceritinib as the first alk tyrosine kinase inhibitor (tki) therapy; orcrizotinib and at least one other alk tki.
varlota 25 mg tabletki powlekane
alvogen pharma trading europe eood - erlotinibum - tabletki powlekane - 25 mg
varlota 50 mg tabletki powlekane
alvogen pharma trading europe eood - erlotinibum - tabletki powlekane - 50 mg
varlota 100 mg tabletki powlekane
alvogen pharma trading europe eood - erlotinibum - tabletki powlekane - 100 mg